Author

H. Kallio-Kokko

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Approach:benchmark study· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:imaging· 1

Frequent Co-Authors

O. Vapalahti· 2 shared S. Kuivanen· 2 shared A. Bergqvist· 1 shared A. Helenius· 1 shared A. Ianevski· 1 shared A. Tobi· 1 shared A. Vitkauskiene· 1 shared B. Mollenhauer· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

O. Vapalahti

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Neuropilin-1 facilitates SARS-CoV-2 cell entry and provides a possible pathway into the central nervous system

L. Cantuti-Castelvetri, R. Ohja, L. Pedro, M. Djannatian, J. Franz, S. Kuivanen, K. Kallio, T. Kaya, M. Anastasina, T. Smura, L. Levanov, L. Szirovicza, A. Tobi, H. Kallio-Kokko, P. Osterlund, , M. Simons

This study shows that neuropilin-1 enhances SARS-CoV-2 infectivity and facilitates viral entry into the central nervous system via the olfactory pathway.

Science · Nov 13, 2020Peer-reviewedMicrobiology

Critical Nodes of Virus-Host Interaction Revealed Through an Integrated Network Analysis

K. Bosl, A. Ianevski, T. T. Than, P. I. Andersen, S. Kuivanen, M. Teppor, E. Zusinaite, U. Dumpis, A. Vitkauskiene, R. J. Cox, H. Kallio-Kokko, A. Bergqvist, T. Tenson, V. Oksenych, M. Bjoras, , R. K. Kandasamy

This study identifies critical host-virus interaction nodes through network analysis and drug re-purposing, revealing key targets for antiviral therapies.

bioRxiv · Feb 13, 2019 · PreprintImmunology